ClinicalTrials.gov
public full text
Public Domain
Phase II Trial of Pentostatin in Steroid Refractory Acute Graft Versus Host Disease
This study will evaluate the response rate to treatment with pentostatin in steroid-refractory acute graft versus host disease.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host Disease#1196358
- NIH Chronic Graft-Versus-Host Disease Consensus Conference 2025 Update.#214137
- Intrathecal Autologous ADRC Treatment of Autoimmune Refractory Epilepsy#1259700
- Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ)#1260667
- Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease#1350830
Record · ID 1408848
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive